ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
73 announcements with these filters
Max Healthcare appointed Ajay Vij and Pawan Kumar Marella as Senior Directors, while N. Venkatesan resigned as Senior Director and Chief Procurement Officer.
Max Healthcare Institute Ltd reported revenue from operations of ₹2,366 Cr (+16.7% YoY) and net profit of ₹323 Cr (+4.9% YoY) for Q1 FY27.
Max Healthcare approved the grant of 3,61,827 stock options to eligible employees under its ESOP 2022 scheme. The grant is split into two tranches.
Max Healthcare's board will meet on August 13, 2026, to consider and approve standalone and consolidated financial results for the quarter ended June 30, 2026.
Max Healthcare provided an update on ongoing NCLT proceedings regarding its subsidiary Kalinga Hospital Ltd. The tribunal allowed a procedural defect to be rectified.
Max Healthcare held its 25th AGM on July 30, 2026, transacting ordinary and special business items, including the adoption of financial statements and dividend declaration.
Max Healthcare has completed the voluntary liquidation of its wholly-owned Nigerian subsidiary, MHC Global Healthcare. This dissolution has no material impact on the company's financials.
Max Healthcare provided an update on petitions filed before the NCLT Cuttack Bench. The tribunal has adjourned the matter until August 4, 2026.
Radiant Life Care Hospital Foundation has been reclassified from Promoter Group to Public category. The reclassification follows approvals from BSE and NSE received on July 1, 2026.
Max Healthcare released its FY 2025-26 BRSR, reporting a turnover of Rs. 8,373.45 Crore. The company operates 63 national healthcare units and serves 12 international markets.
Max Healthcare Institute will hold its 25th AGM on July 30, 2026. The agenda includes declaring a final dividend of Rs. 2 per equity share.
Max Healthcare Institute Ltd disclosed litigation over its subsidiary Kalinga Hospital Ltd and an NCLT interlocutory petition. The filing informs shareholders of the case status.
Max Healthcare allotted ESOP shares, increasing paid-up capital. No financial value disclosed; share count rose from 973.24 million to 973.27 million.
Max Healthcare allotted 29,649 shares under its ESOP 2022 scheme. The paid-up capital increased to ₹973.27 Crore post-allotment.
Max Healthcare received exchange approvals to reclassify Radiant Life Care Hospital Foundation from promoter group to public category. This change is effective immediately.
Max Healthcare faces a Rs. 0.33 Crore penalty from the IT Department for alleged non-prescribed journal entry settlements. The company plans to appeal the order.
Max Healthcare acquired a 100% stake in Yerawada Properties Private Limited. This facilitates setting up a 450-bed super speciality hospital in Pune.
Max Healthcare received a ₹0.32 Crore penalty from the Income Tax Department. The company is currently filing an appeal against this order.
Max Healthcare received an Income Tax penalty of ₹0.11 Crore regarding FY 2018-19 transactions. The company plans to file an appeal against the order.
Max Healthcare received an Income Tax Department order imposing a ₹0.11 Crore penalty. The company is currently appealing the decision.
Max Healthcare delivered Q4 FY26 revenue of INR 2,664 Cr (+10% YoY) and FY26 PAT of INR 1,631 Cr (+22% YoY).
Max Healthcare (MHIL) reports strong FY26 performance with 16% revenue growth and 14% EBITDA growth. The company maintains a 26.2% EBITDA margin while executing an aggressive 8,400+ bed expansion strategy.
Max Healthcare applied to re-classify Radiant Life Care Hospital Foundation from promoter to public category. The change awaits stock exchange approval and no-objection.
The CCI dismissed allegations of dominant position abuse against Max Healthcare's network hospitals. This favorable regulatory outcome removes potential legal liability and operational risk.
Max Healthcare re-appointed Anil Kumar Bhatnagar as Non-Executive Director for 36 months. The board also re-appointed M/s. Chandra Wadhwa & Co. as Cost Auditors.
Max Healthcare recommended a final dividend of ₹2 per equity share. The record date and general meeting schedule will be finalized in due course.
Max Healthcare reported Q4 revenue of ₹2,664 Crore, reflecting 10% YoY growth. Strong operational performance and capacity expansion signal continued growth momentum for investors.
Max Healthcare Institute Ltd reported revenue from operations of ₹2,143 Cr (+12.2% YoY) and net profit of ₹342.2 Cr (+7.3% YoY) for Q4 FY26.
Max Healthcare reported ₹8,536.07 Crore annual consolidated income and recommended a ₹2/- per share dividend. The board also approved a new 712-bed hospital in Lucknow.
Max Healthcare granted 2,15,000 stock options worth ₹13.15 Crore to eligible employees. This employee incentive scheme aligns long-term staff interests with company performance and growth.